Weight loss drug may increase cancer risk

Top Stories

(CNN) – The prescription weight-loss medicine ‘Belviq’ might be associated with an increased risk of cancer.

That’s according to a warning issued by the food and drug administration.

It’s based on the results of clinical trials assessing the safety of the drug ‘Lorcaserin’, sold as Belviq and Belviq RX.

The agency said patients currently taking the drug should talk to their doctors about the potential risks.

Copyright 2019 CNN. All rights reserved.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More Check This Out
Loving Living Local 600x600

Don't Miss

Trending Stories